ReviewPublished 12 October 2026Glutamine metabolic reprogramming in acute and chronic kidney diseases: mechanistic insights and therapeutic implicationsRuotong Xu · Jin Zhao · Minna Liu · Yifan Qiao · Xiaoxuan Ning · Shiren SunFrontiers in Immunologydoi 10.3389/fimmu.2026.1939528
Original ResearchPublished 8 October 2026Amomum tsao-ko volatile oil alleviates renal fibrosis in 5/6 nephrectomy rats through TGF- β 1/SMAD3 and PI3K/AKT signaling pathwaysHuanyue Cui · Meiru Shi · Qing Xu · Shangwen Zhou · Xin Li · Hangyu Wang · Dahong Yao · Ke Zhang · Pinghua Sun · Jinhui WangFrontiers in Pharmacologydoi 10.3389/fphar.2026.1819932
Systematic ReviewPublished 7 October 2026Mapping the aging kidney: a bibliometric atlas of cellular senescence and future frontiers since the 20th centuryJieyan Wang · Mengning Yang · Yifei Li · Yantong Wan · Xiaoying Zhan · Hui LiangFrontiers in Nephrologydoi 10.3389/fneph.2026.1905354
Case ReportPublished 6 October 2026Case Report: Light chain amyloidosis in a patient with low-grade B-cell lymphomaAlex Matthaeus · David Thomas · Hakan R. TokaFrontiers in Nephrologydoi 10.3389/fneph.2026.1959759
ReviewPublished 8 May 2026Gold nanomaterials in the diagnosis and treatment of kidney diseases: from fundamental transport mechanisms to clinical translation prospectsHaicheng Liu · Jingyi Zhao · Jiankun Zheng · Kecheng Lou · Yuwei ZhongFrontiers in Nanotechnologydoi 10.3389/fnano.2026.1846780
Mini ReviewPublished 6 February 2026Genomic and epigenomic landscape of ADPKD: towards precision diagnostics and tailored treatmentsAmankeldi A. Salybekov · Aiman Kinzhebay · Sumi Hidaka · Shuzo KobayashiFrontiers in Epigenetics and Epigenomicsdoi 10.3389/freae.2026.1699528
